IDEA.L Regulatory News (IDEA)

Ideagen PLC

("Ideagen"," the "Company" or the "Group'')

Extension to 2018 Long Term Incentive Plan Awards

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, announces the award of 250,000 share options over the Company's ordinary shares of 1 penny each ("Ordinary Shares") to two of the Group's senior executives under an extension to the Company's 2018 Long Term Incentive Plan (the "2018 LTIP").

The awards reward and reflect their contributions since joining the Group in May 2019. The awards could not for practical reasons have been made sooner.

The principles underpinning the awards are the same as those of the 2018 LTIP award made to Ben Dorks, Chief Executive Officer (announced on 23 October 2018) and to other directors and executives of the Company (announced on 29 March 2019) insofar that they will become eligible to vest on the Company's share price reaching 259 pence over 30 consecutive business days but not before the third anniversary of the grant date. Thereafter, any Ordinary Shares issued in respect of the exercise of any of these options cannot be sold until the fourth anniversary of the grant date except to meet the taxation costs arising on the exercise of those options. They are also subject to continued service throughout as well as the aforementioned share price targets. These options each have an exercise price of 1 penny per Ordinary Share. 

Following the award of these options and the surrender of 250,000 options by a departing employee, there are now 3,429,500 options over Ordinary Shares in issue, representing 1.36% of the issued share capital of the Company.

Enquiries:

About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

A global supplier of regulatory and compliance solutions, Ideagen provides a common software platform and an integrated risk-based approach to meet multi-industry standards, enabling compliance with relevant laws, policies, and regulations.

The Group provides software and services to organisations operating within highly regulated industries such as life sciences, healthcare, banking and finance, insurance, aviation, and aerospace and defence, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

Currently, more than 5,700 organisations use Ideagen's products including eight of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 250 hospitals across the UK and US amongst its client base. For further information please visit www.ideagen.com .